Syringol metabolites as new biomarkers for smoked meat intake.


Journal

The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027

Informations de publication

Date de publication:
01 12 2019
Historique:
received: 07 05 2019
accepted: 08 08 2019
pubmed: 29 9 2019
medline: 3 4 2020
entrez: 28 9 2019
Statut: ppublish

Résumé

Processed meat intake is associated with a higher risk of colorectal and stomach cancers, coronary artery disease, and type 2 diabetes and with higher mortality, but the estimation of intake of different processed meat products in this heterogeneous food group in epidemiological studies remains challenging. This work aimed at identifying novel biomarkers for processed meat intake using metabolomics. An untargeted, multi-tiered metabolomics approach based on LC-MS was applied to 33 meat products digested in vitro and secondly to urine and plasma samples from a randomized crossover dietary intervention in which 12 volunteers consumed successively 3 processed meat products (bacon, salami, and hot dog) and 2 other foods used as controls, over 3 consecutive days. The putative biomarkers were then measured in urine from 474 subjects from the European Prospective Investigation into Cancer and Nutrition (EPIC) cross-sectional study for which detailed 24-h dietary recalls and FFQs were available. Syringol and 4 derivatives of syringol were found to be characteristic of in vitro digests of smoked meat products. The same compounds present as sulfate esters in urine increased at 2 and 12 h after consumption of smoked meat products (hot dog, bacon) in the intervention study. The same syringol sulfates were also positively associated with recent or habitual consumption of smoked meat products in urine samples from participants of the EPIC cross-sectional study. These compounds showed good discriminative ability for smoked meat intake with receiver operator characteristic areas under the curve ranging from 0.78 to 0.86 and 0.74 to 0.79 for short-term and habitual intake, respectively. Four novel syringol sulfates were identified as potential biomarkers of smoked meat intake and may be used to improve assessment of smoked meat intake in epidemiological studies. This trial was registered at clinicaltrials.gov as NCT03354130.

Sections du résumé

BACKGROUND
Processed meat intake is associated with a higher risk of colorectal and stomach cancers, coronary artery disease, and type 2 diabetes and with higher mortality, but the estimation of intake of different processed meat products in this heterogeneous food group in epidemiological studies remains challenging.
OBJECTIVE
This work aimed at identifying novel biomarkers for processed meat intake using metabolomics.
METHODS
An untargeted, multi-tiered metabolomics approach based on LC-MS was applied to 33 meat products digested in vitro and secondly to urine and plasma samples from a randomized crossover dietary intervention in which 12 volunteers consumed successively 3 processed meat products (bacon, salami, and hot dog) and 2 other foods used as controls, over 3 consecutive days. The putative biomarkers were then measured in urine from 474 subjects from the European Prospective Investigation into Cancer and Nutrition (EPIC) cross-sectional study for which detailed 24-h dietary recalls and FFQs were available.
RESULTS
Syringol and 4 derivatives of syringol were found to be characteristic of in vitro digests of smoked meat products. The same compounds present as sulfate esters in urine increased at 2 and 12 h after consumption of smoked meat products (hot dog, bacon) in the intervention study. The same syringol sulfates were also positively associated with recent or habitual consumption of smoked meat products in urine samples from participants of the EPIC cross-sectional study. These compounds showed good discriminative ability for smoked meat intake with receiver operator characteristic areas under the curve ranging from 0.78 to 0.86 and 0.74 to 0.79 for short-term and habitual intake, respectively.
CONCLUSIONS
Four novel syringol sulfates were identified as potential biomarkers of smoked meat intake and may be used to improve assessment of smoked meat intake in epidemiological studies. This trial was registered at clinicaltrials.gov as NCT03354130.

Identifiants

pubmed: 31559413
pii: S0002-9165(22)01338-7
doi: 10.1093/ajcn/nqz222
doi:

Substances chimiques

Biomarkers 0
Pyrogallol 01Y4A2QXY0
pyrogallol 1,3-dimethyl ether 4UQT464H8K

Banques de données

ClinicalTrials.gov
['NCT03354130']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1424-1433

Informations de copyright

Copyright © American Society for Nutrition 2019.

Auteurs

Roland Wedekind (R)

Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon, France.

Pekka Keski-Rahkonen (P)

Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon, France.

Nivonirina Robinot (N)

Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon, France.

Vivian Viallon (V)

Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon, France.

Pietro Ferrari (P)

Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon, France.

Erwan Engel (E)

Micro-contaminants, Aroma and Separative Sciences (MASS) Group, National Institute of Agricultural Research (INRA) UR370 QuaPA, Saint-Genès-Champanelle, France.

Marie-Christine Boutron-Ruault (MC)

Centre for Research in Epidemiology and Population Health (CESP), Faculty of Medicine, University of Paris-Sud, Faculty of Medicine, Versailles Saint-Quentin-en-Yvelines University, French Institute of Health and Medical Research (INSERM), University of Paris-Saclay, Villejuif, France.
Gustave Roussy, Villejuif, France.

Yahya Mahamat-Saleh (Y)

Centre for Research in Epidemiology and Population Health (CESP), Faculty of Medicine, University of Paris-Sud, Faculty of Medicine, Versailles Saint-Quentin-en-Yvelines University, French Institute of Health and Medical Research (INSERM), University of Paris-Saclay, Villejuif, France.
Gustave Roussy, Villejuif, France.

Francesca Romana Mancini (FR)

Centre for Research in Epidemiology and Population Health (CESP), Faculty of Medicine, University of Paris-Sud, Faculty of Medicine, Versailles Saint-Quentin-en-Yvelines University, French Institute of Health and Medical Research (INSERM), University of Paris-Saclay, Villejuif, France.
Gustave Roussy, Villejuif, France.

Tilman Kühn (T)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Theron Johnson (T)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Heiner Boeing (H)

Department of Epidemiology, German Institute of Human Nutrition, Nuthetal, Germany.

Manuela Bergmann (M)

Department of Epidemiology, German Institute of Human Nutrition, Nuthetal, Germany.

Anna Karakatsani (A)

Hellenic Health Foundation, Athens, Greece.
Pulmonary Medicine Department, School of Medicine, National and Kapodistrian University of Athens, "Attikon" University Hospital, Haidari, Greece.

Antonia Trichopoulou (A)

Hellenic Health Foundation, Athens, Greece.

Heleni Peppa (H)

Hellenic Health Foundation, Athens, Greece.

Claudia Agnoli (C)

Epidemiology and Prevention Unit, IRCCS National Cancer Institute Foundation, Milan, Italy.

Maria Santucci de Magistris (M)

AOU Federico II, Naples, Italy.

Domenico Palli (D)

Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Carlotta Sacerdote (C)

Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.

Rosario Tumino (R)

Cancer Registry and Histopathology Department, "Civic-M.P.Arezzo" Hospital, ASP, Ragusa, Italy.

Marc J Gunter (MJ)

Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon, France.

Inge Huybrechts (I)

Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon, France.

Augustin Scalbert (A)

Nutrition and Metabolism Section, International Agency for Research on Cancer, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH